123ArticleOnline Logo
Welcome to 123ArticleOnline.com!
ALL >> Health >> View Article

Unlocking Potential: Exploring Opportunities In Oligonucleotide Synthesis Market

Profile Picture
By Author: Markets and Markets
Total Articles: 161
Comment this article
Facebook ShareTwitter ShareGoogle+ ShareTwitter Share

According to a new report by MarketsandMarkets™ – Oligonucleotide Synthesis Market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029.

One of the key factors driving the market growth is the growing acceptance of alternate therapies such as oligonucleotide-based therapies for the treatment of neurological and rare The incorporation of synthesized oligonucleotides to treat various diseases also supports market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350

Probes are an important subsegment in the market for synthesized oligonucleotides. The segment accounted for the second-largest market share of the synthesized oligonucleotide market. This is due to high specificity and sensitivity of probes allowing their use in genetic research, pathogen detection, clinical diagnostics, and the study of gene expression patterns, offering insights into diverse biological processes and disease mechanisms. Techniques such as fluorescence in situ hybridization ...
... (FISH) utilize these probes for the detection of various genetic abnormalities that the root cause of several birth defects, neurological conditions and cancers among others.

By end user, hospitals accounted for the largest share of the oligonucleotide synthesis market in 2023. Growth in this market is largely driven by the significant number of FDA-approvals for oligonucleotide-based drugs especially antisense oligonucleotide drugs for rare and neurological diseases, increasing awareness towards alternative therapies and growing health-care spending. Ongoing research to develop oligonucleotide-based drugs for more common diseases such as cardiovascular diseases, supported by availability of reimbursement policies in developed economies are aiding this segment’s growth.

In 2023, PCR accounted for the largest share of the research application subsegment of the oligonucleotide synthesis market. PCR technologies such as real-time PCR or quantitative PCR (qPCR) used for both qualitative and quantitative analysis in the fields of molecular diagnostics, medicine, microbiology, and forensic biology are driving end-user demand. These PCR applications utilize sequence-specific primers, thus boosting the market for oligos (which are used as probes and primers) in the PCR market.

The North America region is expected to show the highest CAGR of the oligonucleotide synthesis market. The growing investments in research and development by major pharmaceutical & biotechnology companies, increasing application of oligonucleotides in pharmaceutical drug research, and growing public & private sector investments in genomics and related technologies are expected to aid market growth in the North America.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350

Oligonucleotide Synthesis Market Dynamics:

Drivers:

Increasing use of synthesized oligos in therapeutic and diagnostic applications
Technological advancements
Growing government investments in life science research and synthetic biology
Growing focus on precision/personalized medicine
Restraints:

Complexities associated with therapeutic oligonucleotides
Opportunities:

Increasing R&D investments by key players in emerging economies
Challenge:

Lack of standard regulations
Delivery of oligonucleotide drugs to specific targets
Key Market Players of Oligonucleotide Synthesis Industry:

Some leading players operating in the oligonucleotide synthesis market are Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Eurofins Scientific (Luxembourg), LGC Limited (UK), Agilent Technologies, Inc. (US), Kaneka Corporation (Japan), Maravai Lifesciences holdings, Inc. (US), Azenta, Inc. (US), Twist Bioscience Corporation (US) and Genscript Biotech Corporation (US). Major players in the oligonucleotide therapeutics market are Biogen Inc. (US), Alnylam Pharmaceuticals, Inc. (US), Sarepta Therapeutics, Inc. (US), Astrazeneca (UK), Astellas Pharma Inc. (Japan), Jazz Pharmaceuticals Plc (Ireland), Nippon Shinyaku, Co. Ltd. (Japan), Ionis Pharmaceuticals, Inc. (US) and Novartis AG (Switzerland).

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side – 30%
By Designation: Managers- 45%, CXOs, and Director level – 30%, and Executives – 25%
By Region: North America -35%, Europe – 25%, Asia-Pacific -15%, Latin America -10%, Middle East- 10%, Africa- 5%
Recent Developments of Oligonucleotide Synthesis Industry:

In November 2023, LCG Biosearch Technologies, a business unit of LGC Limited, acquired PolyDesign to enhance its oligonucleotide synthesis capabilities using PolyDesign’s frit technology.
In October 2023, Integrated DNA Technologies (IDT), a subsidiary of Danaher Corporation, opened its therapeutic oligonucleotide manufacturing facility in Coralville, Iowa. This facility will produce reagents for cGMP cell & gene therapy, including single-guide RNAs and HDR donor oligos.
Oligonucleotide Synthesis Market – Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall oligonucleotide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following pointers:

Analysis of key drivers (e.g., Increasing use of synthesized oligos in therapeutic and diagnostic applications, Technological advancements), restraints (e.g., complexities associated with oligonucleotide-based drugs), opportunities (e.g., increasing pharma R&D investments in emerging economies), and challenges (e.g., lack of standard regulations) are influencing the growth of the oligonucleotide synthesis market.
Product Approvals: Detailed insights on newly approved products of the oligonucleotide synthesis market.
Market Development: Comprehensive information about lucrative markets – the report analyses the oligonucleotide synthesis market across varied regions.
Market Diversification: Exhaustive information about new products, recent developments, and investments in the oligonucleotide synthesis market.
Pipeline Analysis: Comprehensive information about products under clinical trials.
Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players including Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), among others offering products for research & diagnostic applications and Biogen Inc. (US), Alnylam Pharmaceuticals, Inc. (US), Sarepta Therapeutics, Inc. (US) among others offering products for therapeutic applications.
Get access to the latest updates on Oligonucleotide Synthesis Companies and Oligonucleotide Synthesis Industry Growth

Content Source: https://www.prnewswire.com/news-releases/oligonucleotide-synthesis-market-worth-19-7-billion–marketsandmarkets-302128509.html

Total Views: 51Word Count: 907See All articles From Author

Add Comment

Health Articles

1. Naturopathy Clinic In Ahmedabad
Author: naturecurebest

2. Decoding The Importance Of Natural Hairline Design In Hair Transplantation
Author: Henry Davis

3. Strategies For Hiring And Retaining Skilled Speech Therapists In Healthcare
Author: John

4. How Medical Assistants Improve Workflow In High-volume Healthcare Settings
Author: John

5. Why Hiring Skilled Pharmacy Technicians Is Critical For Streamlined Pharmacy Operations
Author: John

6. How Pharmacists Enhance Efficiency In Hospital And Clinical Settings
Author: John

7. The Essential Role Of Hiring Registered Nurses (rns) For Quality Patient Care
Author: John

8. The Role Of Artificial Intelligence In Robotic Gi Surgery
Author: Dr. Srivatsan Gurumurthy

9. How To Use Shatter Safely For Beginners: A Comprehensive Guide
Author: Henry

10. How To Choose The Best Multispeciality Hospital In Jaipur For Your Healthcare Needs?
Author: YATIKA

11. How Nutraceutical Manufacturing Companies Are Shaping The Future Of Health
Author: AjayRaj

12. Reclaim Vitality: The Science Behind Mitochondrial Biogenesis
Author: sonya

13. Common Weight Loss Challenges And How To Overcome Them
Author: Alexis Pelloe

14. Scheduling A Denture Consultation- The 4 Benefits
Author: John Jerry

15. 4 Reasons Why Implant Dentures Are A Great Option
Author: John Jerry

Login To Account
Login Email:
Password:
Forgot Password?
New User?
Sign Up Newsletter
Email Address: